References
- De Barbieri A. Synthesis and screening of substances acting by alkylation and antimetabolic inhibition. A. Ge. Me. Ge. 1968; 17: 67
- De Barbieri A., Chiappino G., Di Vittorio R., Golferini A., Maugeri M., Mistretta A. P., Perrone F., Tassi G. C., Temelcou O., Zappelli P. Peptichemio: A synthesis of pharmacological, morphological, biochemical and biomolecular investigation. Proc. Synp. Peptichemio, Milan. 1972
- Yagi M. J., Bekesi J. G., Daniel M. D., Holland J. F., De Barbieri A. Increased cancericidal activity of PTT. 119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanina derivative with carrier amino acid. I. In vitro cytotoxicity. Cancer Chemother. Pharmacol. 1984; 12: 70
- Yagi M. J., Zanjani M., Holland J. F., Bekesi J. G. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloro ethyl)amino-L-phenylalanine derivative with carrier amino acid. II. In vivo bioassay. Cancer Chemother. Pharmacol. 1984; 12: 77
- Ehrke M. J., Mihich E. Clinical chemotherapy Vol. III-Antineoplastic chemotherapy., B. Berkada, G. Karrer, Mathe. George Thieme Verlag, Stuttgart, 475
- Ehrke M. J., Mihich E. Effect of anticancer agent on immune responses. Trends Pharmacol. Sci. 1985; 6: 412
- North R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J. Exp. Med. 1982; 155: 1063
- Mihich E., North R. J., Ishizuka M. Biological Responses in Cancer : Progress Towards Potential Applications Vol. 3 Immunomodulation by Anticancer Drugs, E. Mihich, Y. Sakurai. Plenum, New York 1985; 71
- Herberman R. B., Aoki T., Nunn M., Lavrin D. H., Soares N., Gazdar A., Holden H., Chang K. S. S. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J. Natl. Cancer Inst 1974; 53: 1103
- Kerkhaert J. A., Hofhuis F. M., Willers J. M. Effect of variation in time and dose of cyclophosphamide injection on delayed hypersensitivity and antibody formation. Cell. Immunol. 1977; 29: 232
- Jerne N. K., Henry C., Nordin A. A., Fujj H., Koros A. M. C., Lefkovits I. Plaque forming cell: methodology and theory. Transplant Rev. 1974; 18: 130
- Campanile F., Puccetti P., Angeli G., Fioretti M. C., Bonmassar E. Experimental studies on mice challenged intracerebrally with Pseudomonas aeruginosa. Int. J. Tiss. React. 1984; 6: 421
- Cheever M. A., Greenberg P. D., Fefer A. Biological Responses in Cancer, E. Mihich, Y. Sakurai. Plenum, New York 1984; Vol. 2: 145
- Berd D., Maguire H. C., Mastrangelo M. J. Potentation of humoral immunity by low doses cyclophosphamide. Cancer Research 1984; 44: 5439
- Giampietri A., Bonmassar E. Drug-induced modulation of immune responses in mice: effects of 5-(3, 3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) and cyclophosphamide (CY). J. Immunopharmacol. 1978–79; 1: 61
- Bianchi R., Nardelli B., Allegrucci M., Fioretti M. C. Efficacia terapeutica del PTT-119 valutata “in vivo” in modelli sperimentali. G. Ital. Chemioter. 1985; 32: 1
- Benner R., Walters E. A. J., Bril H., Molendijk A., van Oudenaren A. Regulation of delayed type hypersensitivity to host histocompatibility antigens during graft-versus-host reactions. Immunol. Rev. 1985; 88: 25
- Ramshaw I. A., McKenzie I. F. C., Bretscher P. A., Parish C. R. Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-la sera. Cell. Immunol. 1977; 31: 364
- Dialynas D. P., Wilde D. B., Marrack B., Pierres A., Wall K. A., Havraw W., Otten G., Loken M. R., Pierres M., Kappler J., Fitch F. W. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK 1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with Class II MHC antigen-reactivity. Immunol. Rev. 1983; 74: 29
- Habu S., Raff M. C. Accessory cell dependence of lectin-induced proliferation of mouse T lymphocytes. Eur. J. Immunol. 1977; 7: 451
- Diamantstein T., Klos M., Han H., Kaufmann S. H. E. Direct in vitro evidence for different susceptibilitis to 4-hydroperoxi cyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune responses. J. Immunol. 1981; 126: 1717